Hall, Sara
Janelidze, Shorena
Surova, Yulia
Widner, Håkan
Zetterberg, Henrik
Hansson, Oskar
Article History
Received: 21 May 2018
Accepted: 20 August 2018
First Online: 5 September 2018
Competing Interests
: S.H., S.J., and Y.S. report no competing interests. H.W. is on the advisory board for CBD Solutions AB and NeuroVive AB, H.Z. has served at advisory boards of Eli Lilly, Roche Diagnostics and Pharmasum Therapeutics and is co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (not involved in the study). O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio.